---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-002723"
form_type: "8-K"
ticker: null
cik: "0000922247"
company_name: "Cyclo Therapeutics, Inc."
filed_at: "2025-02-04T23:59:59+00:00"
generated_at: "2026-05-27T03:50:29.898957+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclo Therapeutics extends merger deadline to March 31, 2025 and issues $2M convertible note to Rafael

## Summary
- Merger Agreement End Date extended from Feb 15 to March 31, 2025 via Amendment No. 2 with Rafael Holdings.
- Company issued $2M convertible promissory note to Rafael (5% interest, matures March 31, 2025) for working capital.
- Prior notes' maturity dates also extended to March 31, 2025.
- Rafael Holdings owns ~39.5% of Cyclo common stock.

## SEC filing metadata
- accession: 0001437749-25-002723
- form_type: 8-K
- cik: 0000922247
- company_name: Cyclo Therapeutics, Inc.
- filed_at: 2025-02-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/0001437749-25-002723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/ctdh20250204_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-002723
- JSON: https://secwatch.observer/filing/0001437749-25-002723.json
- Plain text: https://secwatch.observer/filing/0001437749-25-002723.txt

## Key facts
- Debt Financings
  Cyclo Therapeutics, Inc. incurred convertible notes of $2,000,000.00 with Rafael at 5% per annum maturing March 31, 2025.
  - Instrument: convertible notes
  - Principal: $2,000,000.00
  - Counterparty: Rafael
  - Rate: 5% per annum
  - Maturity: March 31, 2025
  - Event: incurrence
  source text: Eighth Amended and Restated Note Purchase Agreement (the “Agreement”) with Rafael pursuant to which the Company issued and sold a convertible promissory note in the principal amount of $2,000,000.00 (the “Note”) to Rafael.
  evidence_url: https://www.sec.gov/Archives/edgar/data/922247/000143774925002723/0001437749-25-002723-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.